NORTHFIELD, Ill.--(BUSINESS WIRE)--Recognizing a need for evidence-based recommendations to guide molecular testing in the management of patients with cancer, the College of American Pathologists (CAP ...
Correlation between clinical-pathological parameters and family history to detect mutations in MLH1, MSH2, and MSH6. Background: Data from studies performed at tertiary referral centers suggest that ...
Researchers from Northwestern University and Yale University have presented new preclinical data for KL-50, a small molecule under investigation for the treatment of glioblastoma. KL-50 was designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback